News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Memorial Sloan Kettering Cancer Center
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/10/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/17/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/07/2018 |
SC 13G
| Memorial Sloan-Kettering Cancer Center reports a 8% stake in Y-mAbs Therapeutics, Inc. |
| 02/12/2018 |
SC 13G/A
| Memorial Sloan-Kettering Cancer Center reports a 1.5% stake in Actinium Pharmaceuticals, Inc. |
| 02/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/15/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/01/2016 |
4
| Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Sold 23,500 shares
@ $1.8, valued at
$42.3k
Sold 1,500 shares
@ $1.805, valued at
$2.7k
Sold 30,474 shares
@ $1.81, valued at
$55.2k
Sold 200 shares
@ $1.8125, valued at
$362.5
Sold 300 shares
@ $1.815, valued at
$544.5
Sold 100 shares
@ $1.82, valued at
$182
Sold 25,188 shares
@ $1.8, valued at
$45.3k
Sold 6,400 shares
@ $1.81, valued at
$11.6k
Sold 200 shares
@ $1.815, valued at
$363
Sold 25,100 shares
@ $1.82, valued at
$45.7k
Sold 800 shares
@ $1.83, valued at
$1.5k
|
|
| 08/30/2016 |
4
| Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Sold 12,998 shares
@ $1.7, valued at
$22.1k
Sold 12,002 shares
@ $1.71, valued at
$20.5k
Sold 12,500 shares
@ $1.71, valued at
$21.4k
Sold 12,500 shares
@ $1.72, valued at
$21.5k
|
|
| 08/17/2016 |
4
| Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Sold 4,439 shares
@ $1.72, valued at
$7.6k
Sold 4,629 shares
@ $1.72, valued at
$8k
Sold 400 shares
@ $1.725, valued at
$690 |
|
| 07/14/2016 |
4
| Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Sold 3,000 shares
@ $1.8, valued at
$5.4k
Sold 100 shares
@ $1.81, valued at
$181 |
|
| 07/07/2016 |
4
| Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Sold 6,000 shares
@ $1.82, valued at
$10.9k
Sold 4,340 shares
@ $1.83, valued at
$7.9k
Sold 10,500 shares
@ $1.8, valued at
$18.9k
|
|
| 07/05/2016 |
4
| Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Sold 15,200 shares
@ $1.8, valued at
$27.4k
Sold 300 shares
@ $1.8025, valued at
$540.8
Sold 300 shares
@ $1.805, valued at
$541.5
Sold 3,350 shares
@ $1.82, valued at
$6.1k
Sold 44,841 shares
@ $1.8, valued at
$80.7k
Sold 3,200 shares
@ $1.8001, valued at
$5.8k
Sold 200 shares
@ $1.8015, valued at
$360.3
Sold 100 shares
@ $1.8025, valued at
$180.3
Sold 11,350 shares
@ $1.805, valued at
$20.5k
Sold 25,800 shares
@ $1.81, valued at
$46.7k
Sold 7,362 shares
@ $1.8101, valued at
$13.3k
|
|
| 07/05/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 06/17/2016 |
4
| Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Sold 33,619 shares
@ $1.9, valued at
$63.9k
|
|
| 06/06/2016 |
4
| Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Sold 11,000 shares
@ $2, valued at
$22k
Sold 6,790 shares
@ $2.02, valued at
$13.7k
|
|
| 06/02/2016 |
4
| Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Sold 18,110 shares
@ $1.9, valued at
$34.4k
Sold 1,890 shares
@ $1.905, valued at
$3.6k
Sold 19,700 shares
@ $1.92, valued at
$37.8k
Sold 300 shares
@ $1.9201, valued at
$576
Sold 23,837 shares
@ $1.93, valued at
$46k
Sold 100 shares
@ $1.9301, valued at
$193
Sold 600 shares
@ $1.9315, valued at
$1.2k
Sold 300 shares
@ $1.935, valued at
$580.5
Sold 56,954 shares
@ $1.94, valued at
$110.5k
Sold 790 shares
@ $1.945, valued at
$1.5k
Sold 6,755 shares
@ $1.95, valued at
$13.2k
|
|
| 05/31/2016 |
4
| Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Sold 27,168 shares
@ $1.92, valued at
$52.2k
Sold 12,700 shares
@ $1.93, valued at
$24.5k
Sold 200 shares
@ $1.935, valued at
$387 |
|
| 05/26/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/26/2016 |
4
| Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Sold 3,041 shares
@ $2.06, valued at
$6.3k
Sold 19,759 shares
@ $2.07, valued at
$40.9k
Sold 100 shares
@ $2.0725, valued at
$207.3
Sold 1,000 shares
@ $2.075, valued at
$2.1k
Sold 3,692 shares
@ $2.08, valued at
$7.7k
Sold 100 shares
@ $2.09, valued at
$209
Sold 1,800 shares
@ $2, valued at
$3.6k
Sold 200 shares
@ $2.0025, valued at
$400.5
Sold 500 shares
@ $2.005, valued at
$1k
Sold 7,600 shares
@ $2.01, valued at
$15.3k
Sold 400 shares
@ $2.0125, valued at
$805 |
|
| 04/21/2016 |
4
| Memorial Sloan-Kettering Cancer Center (10% Owner) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Sold 4,517 shares
@ $2.065, valued at
$9.3k
Sold 2,133 shares
@ $2.07, valued at
$4.4k
Sold 3,420 shares
@ $2.0701, valued at
$7.1k
Sold 600 shares
@ $2, valued at
$1.2k
Sold 200 shares
@ $2.01, valued at
$402
Sold 4,000 shares
@ $2.02, valued at
$8.1k
Sold 18,224 shares
@ $2.03, valued at
$37k
Sold 10,473 shares
@ $2.04, valued at
$21.4k
Sold 9,300 shares
@ $2.04, valued at
$19k
Sold 3,700 shares
@ $2.05, valued at
$7.6k
Sold 49,509 shares
@ $2, valued at
$99k
|
|
| 04/21/2016 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
|
|